JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M609430200 on November 27, 2006

J. Biol. Chem., Vol. 282, Issue 4, 2221-2228, January 26, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/4/2221    most recent
M609430200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haraguchi, N.
Right arrow Articles by Tani, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haraguchi, N.
Right arrow Articles by Tani, T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mutations in the SF1-U2AF59-U2AF23 Complex Cause Exon Skipping in Schizosaccharomyces pombe*

Noriko Haraguchi{ddagger}, Tomoko Andoh{ddagger}, David Frendewey§, and Tokio Tani{ddagger}1

From the {ddagger}Department of Biological Sciences, Graduate School of Science and Technology, Kumamoto University, Kumamoto 860-8555, Japan and §Regeneron Pharmaceuticals, Inc., Tarrytown, New York 10591-6707

Received for publication, October 5, 2006 , and in revised form, November 20, 2006.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
To identify genes involved in the mechanism to ensure ordered 5' to 3' exon joining in constitutively spliced pre-mRNAs, we screened for mutants that cause exon skipping in the fission yeast Schizosaccharomyces pombe using a reporter plasmid, which contains the ura4+ gene with the nda3 intron 1-exon 2-intron 2 sequence. The reporter plasmid was designed to produce the functional ura4+ mRNA, when the central nda3 exon is skipped during the splicing reaction. We mutagenized cells harboring the plasmid by UV irradiation and isolated 34 ura+ mutants that grew on minimal medium. Of those, eight mutants were found to be temperature sensitive (ts) for growth. Complementation analyses revealed that the ts mutants belong to three distinct complementation groups named ods (ordered splicing) 1, 2, and 3. RT-PCR analyses showed that products of exon skipping were actually generated in the ods mutants. We cloned the genes responsible for the ods mutations, and found that ods1+, ods2+, and ods3+ encode splicing factors Prp2p/U2AF59, U2AF23, and SF1, respectively, which form a SF1-U2AF59-U2AF23 complex involved in recognition of the branch-point and 3' splice site sequences in a pre-mRNA. We also showed that mutations in the SF1-U2AF59-U2AF23 binding sequences in the reporter plasmid result in exon skipping in wild-type S. pombe cells. In addition, drugs that decrease the rate of transcription elongation were found to suppress the exon skipping in the ods mutants. These results suggest that co-transcriptional recognition of a nascent pre-mRNA by the SF1-U2AF59-U2AF23 complex is essential for ordered exon joining in constitutive splicing in S. pombe.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The coding regions of typical metazoan genes are interrupted by multiple noncoding introns. Removal of introns from a pre-mRNA (pre-mRNA splicing) is thus essential for expression of eukaryotic genes. The splicing reaction takes place in a dynamic complex termed a spliceosome (for a review, see Ref. 1). A set of five small nuclear ribonucleoprotein particles (snRNPs)2 and more than 50 accessory proteins are assembled onto each intron to form the spliceosome. Experiments using the in vitro splicing system revealed that, at the initial step for the spliceosome formation, the U1 snRNP binds to the 5' splice site through base pairing between the splice site and the U1 snRNA. The branchpoint, which is required for formation of a lariat intermediate, and the polypyrimidine tract are bound by SF1 (also called BBP in Saccharomyces cerevisiae) and the large subunit of U2AF (U2AF65), respectively (for a review, see Ref. 2). In addition, the small subunit of U2AF (U2AF35) binds to AG at the 3' splice site. The earliest complex containing the U1 snRNP and U2AF in spliceosome assembly is called the E (early) or commitment complex. The U2 snRNP, the U4/U5/U6 tri-snRNP and other splicing factors are then assembled sequentially to form the final spliceosome, in which the splicing reaction is carried out.

In a multi-intron pre-mRNA, alterations in splice site choice can produce diversity in protein synthesis. Such alternative pre-mRNA splicing is now known to be as high as 60% for human genes (3). In general, alternative splicing occurs in specific sets of introns and exons, and is carried out in a highly regulated manner (3). Most other exons, in contrast, are joined in an orderly manner and are included in the final mature mRNA that directs the synthesis of a functional protein (constitutive splicing). Although binding of regulatory proteins to pre-mRNA is shown to activate or repress the use of splice sites in alternative splicing (4, 5), little is known about the mechanisms that ensure ordered exon joining in constitutive splicing.

In the fission yeast Schizosaccharomyces pombe, more than 43% of the protein-coding genes contain introns, and individual genes can contain up to 15 introns (6), some of which have been reported to be alternatively spliced (6–8). These facts indicate that the S. pombe splicing system is closer to that of mammals than is the system of S. cerevisiae, in which only a small portion of the genes (about 4% of the total genes) contains an intron and most of them have only one intron per gene (9). From that point of view, we have thought that S. pombe is a good model organism to analyze the splicing mechanisms including that for constitutive splicing.

In this report, we isolated three classes of mutations that cause exon skipping in S. pombe and revealed that the genes carrying these mutations encode subunits of the SF1-U2AF59-U2AF23 complex. We also showed that exon skipping in these mutants was repressed when cells are treated with inhibitors of transcription elongation. These results suggest that the initial co-transcriptional recognition of pre-mRNA by the SF1-U2AF59-U2AF23 complex is important to ensure ordered exon joining in constitutive splicing.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
S. pombe Strains and General Methods—S. pombe strains used in this study are listed in Table 1. The complete media YPD or YE (10, 11) and the minimal medium MM (10) were used for standard culture of S. pombe strains. Appropriate growth supplements (adenine, leucine, and uracil, 80 mg/liter each) were added to MM. SPA medium was used for induction of mating and sporulation of S. pombe (10). Medium containing 2% agar was used for plating. Standard genetic methods used for S. pombe were as described (12).


View this table:
[in this window]
[in a new window]

  		TABLE 1
S. pombe strains used in this study

 
Construction of a Reporter Plasmid to Detect Exon Skipping—To construct a reporter plasmid to detect exon skipping in S. pombe, we synthesized the intron 1-exon 2-intron 2 sequence of the S. pombe nda3+ gene (encodes beta-tubulin, 13) by PCR amplification from the cloned gene (kindly provided by M. Yanagida) and inserted it into the StuI site of the ura4+ gene on the pURA4 plasmid (14), which carries the ARS1 autonomously replicating sequence and the S. cerevisiae LEU2 gene. The resultant ura4 construct (pURA4beta) was sequenced to confirm that the inserted beta-tubulin sequence and the ura4+ coding sequence are intact.

Isolation of ods Mutants—Cells from an S. pombe strain (UR471, Table 1) that is auxotrophic for leucine and uracil were transformed with pURA4beta and cultured for 20 h at 26 °C in minimal medium (MM) containing uracil (MMU). After two washes with MM, cells were spread on MM plates at a density of about 500,000 cells per plate. Cells were then irradiated with a 254-nm germicidal UV light at a flux of 100 J/m2 using a CL-1000 UV cross-linker (UVP Inc., Cambridge, UK), and incubated at 26 °C for up to 10 days. Colonies that grew on MM plates were then selected. Of those, mutants that are temperature sensitive for growth were chosen for further analyses. To check that their growth on MM plates was due to exon-skipped transcripts from pURA4beta, the plasmid was dropped from cells by streaking on YPD plates successively several times. Growth abilities of the mutants that lost the plasmid were then analyzed. All the isolated mutants could not grow on MM plates without pURA4beta.

Genetic Analyses—The isolated mutants were crossed with a leu– ura– strain (UR470, Table 1) and tetrad analysis was performed. Analysis of 10 tetrads for each mutant showed that the ts and wild-type phenotypes segregated 2:2 in all cases. Each mutant was backcrossed at least three times with UR470. Co-segregation of the exon skipping phenotype (ura+) with the ts phenotype was confirmed by re-transformation of backcrossed mutants with pURA4beta. To determine whether the ts mutations in isolated mutants are dominant or recessive, heterozygous diploids were obtained by crossing with strain RS1 (Table 1). All diploids grew at the restrictive temperature of 37 °C, demonstrating that the mutations were recessive.

Preparation of RNA and RT-PCR—Cells containing pURA4beta were grown in 10 ml of appropriate medium (MMU for wild-type cells and MM for ods muants) to mid-log phase at the permissive temperature (26 or 30 °C), and then shifted to the restrictive temperature (37 °C) for 2 h. In the case of snh29, cells were cultured to the mid-log phase at 26 °C and shifted to the restrictive temperatures of 30 or 36 °C for 2 h. Cells were washed twice with sterile water, and total RNA was prepared by glass beads disruption as described by Urushiyama et al. (15). The yield of total RNA was usually 40–200 µg.

RNA samples were treated with RQ1 RNase free DNase (Promega) in 5 mM MgCl2 and 50 mM Tris-HCl (pH 8.0) at 37 °C for 1 h to remove contaminating genomic DNA, followed by extraction with phenol/chloroform/isoamyl alcohol and ethanol precipitation. Reverse transcription was then performed using Ready-To-Go You-Prime First-Strand Beads (Amersham Biosciences), 3.33 µM gene-specific RT primer (tub-4: 5'-CTTTGGAAGACATTTCAGC-3') or oligo dT (50 mer), and 2 µg of total RNA according to the manufacturer's protocol. PCR was done in a solution containing Ex Taq polymerase (TaKaRa), 0.2 mM dNTP mix, 3.33 µM 5'-forward primer (tub-3: 5'-ATATGCATCTGGTGTGTAC-3'), 3.33 µM tub-4 primer, and 2 µl of reverse-transcribed cDNAs. The tub-3 and tub-4 primers are complementary to the 3'-end of the ura4+ first exon and the 5'-end of the ura4+ second exon, respectively. The amplified products were separated on a 5% polyacrylamide gel and stained with ethidium bromide solution (1 µg/ml).

Southern Blot Analysis—After electrophoresis on a 5% polyacrylamide gel, the amplified products were transferred onto a Gene Screen Plus filter (PerkinElmer Life Sciences) by capillary blotting and detected by hybridization with an oligonucleotide probe complementary to the sequence in the ura4+ mRNA produced by the exon skipping spliced product (5'-TCTTTGAGGCCTTGTATA-3'), which was end-labeled with [{gamma}-32P]ATP and T4 polynucleotide kinase (16). Hybridization was performed in a solution containing 6x SSC, 50 mM sodium phosphate, 5x Denhardt's solution, 0.1% SDS, 100 µg/ml boiled salmon sperm DNA and the 32P-labeled probe at 42 °C. After hybridization, filters were exposed to a Fuji imaging plate and analyzed using a Bioimaging Analyzer BAS-1500 (Fuji Photo Film Co., Ltd.).

Site-directed Mutagenesis of pURA4beta—The various mutations of pURA4beta were generated by site directed mutagenesis of single-stranded DNA using QuikChange II site-directed mutagenesis kit (Stratagene) with oligonucleotides listed in Table 2.


View this table:
[in this window]
[in a new window]

  		TABLE 2
List of oligonucleotides

 


Figure 1
View larger version (15K):
[in this window]
[in a new window]

  		FIGURE 1.
A, structure of the pURA4beta reporter plasmid. The intron 1-exon 2-intron 2 region of the S. pombe beta-tubulin gene (nda3+) was amplified by PCR and inserted into the StuI site of the ura4+ gene. B, splicing patterns of the transcripts from the chimeric ura4 gene in pURA4beta. Transcripts in which the internal exon is included produce non-functional Ura4p, whereas transcripts subjected to exon skipping produce functional Ura4p.

 
Analyses of Exon Skipping using Drugs That Slow the Transcription Elongation—Strain UR471 (Table 1) or ods1-1 cells harboring pURA4beta were cultured in MM containing uracil at 26 °C to A600 of 0.5. After washing once with sterilized water, cells were resuspended in MM containing 6-azauracil (6-AU, 0.08 mg/ml) or mycophenolic acid (MPA, 0.1 mg/ml) and then incubated with shaking for 4 h at 26°C. After cultivation, total RNAs were isolated and subjected to RT-PCR analyses with the tub-3 and tub-4 primers, as described above, to detect the exon skipping.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
Isolation of S. pombe Mutants That Cause Exon Skipping—To isolate S. pombe mutants that induce exon skipping, we constructed a reporter plasmid (pURA4beta) carrying a chimeric ura4+ gene, in which the intron 1-exon 2-intron 2 sequence of the nda3+ gene was inserted at a site previously shown to tolerate the insertion of an artificial intron (17) (Fig. 1A). In ura– cells harboring pURA4beta, if skipping of the inserted beta-tubulin exon occurs, then functional ura4+ mRNA is regenerated, and the cells are expected to become prototrophic for uracil, resulting in growth on minimal medium (MM) (Fig. 1B). We mutagenized about 15 million cells containing pURA4beta by UV irradiation and isolated 34 ura+ mutants that grew on MM plates. Of those, eight mutants (snh4, 19, 25, 28, 29, 32, 33, and 34) were temperature-sensitive for growth (Fig. 2A) and chosen for further analyses.

To exclude a possibility that the ura+ phenotype of the isolated mutants resulted from mutations in the intron-containing ura+ gene of the reporter plasmid, we dropped the plasmid from the mutants and then re-introduced pURA4beta. As expected, the mutant cells without pURA4beta could not grow on MM plates; whereas, mutant cells re-transformed with pURA4beta recovered the ability to grow on MM plates (Fig. 2B). These results indicated that the expression of the ura+ phenotype of the isolated mutants depended on pURA4beta and probably resulted from exon skipping in the splicing of pre-mRNAs from the intron-containing ura4+ gene.

The mutants were backcrossed three times with a wild-type strain to remove extra mutations. Tetrad analysis showed 2:2 segregation of the ts– and ts+ phenotypes in all cases, suggesting that the ts– phenotype is caused by a single mutation. The ability to grow on MM co-segregated with the ts– phenotype in all the mutants, indicating that in each mutant a single mutation is responsible for both phenotypes. All mutations are recessive, as the heterozygous diploids with the wild-type alleles grew well at the restrictive temperature.

After backcrossing, each mutant was subjected to complementation analysis in all combinations. As shown in Fig. 2C, the isolated mutants fell into three different complementation groups named ods (ordered splicing) 1 to 3. We categorized snh4, 25, 28, 29, and 32 in ods1, snh19 in ods2, and snh33 and 34 in ods3, respectively.

Detection of Exon Skipping Products in the ods Mutants—To demonstrate that exon skipping is induced in ods mutants, we isolated total RNAs from wild type (UR471) and ods cells carrying pURA4beta and subjected them to RT-PCR analyses using primers for amplification of the intron-containing region of the chimeric ura4+ gene. The amplified products were then analyzed by an electrophoresis on a 5% polyacrylamide gel, followed by Southern blot analysis using an oligonucleotide probe that specifically recognized the exon-skipped product. In ods1, ods2, and ods3 cells we observed three major bands corresponding to pre-mRNAs with two introns, partially spliced mRNAs containing only the second intron and constitutively spliced mature mRNAs (Fig. 3). In addition to these major bands, a small amount of an amplified product predicted to be the exon-skipped ura4+ mRNA was observed in gels stained with ethidium bromide (Fig. 3, upper panel). Southern blot analysis (Fig. 3, lower panel) and the sequence analysis (not shown) of the products revealed that those are actually derived from the exon-skipped transcripts. In contrast, bands for pre-mRNA with two introns and exon-skipped products were barely detected in the wild-type cells. From these results, we concluded that skipping of the central exon in the chimeric ura4+ pre-mRNA was induced in the isolated mutants, although the amount of the exon skipping products is low compared with those for constitutively spliced mRNAs or unspliced products.


Figure 2
View larger version (58K):
[in this window]
[in a new window]

  		FIGURE 2.
A, temperature sensitive growth of the isolated mutants. Each mutant and the wild type strain (UR471) was streaked on YEALU plates and incubated at indicated temperatures for 5 days. B, growth of the isolated mutants on MM plates depends on the pURA4beta plasmid. The mutant cells transformed with the vector could not grow on an MM plate. C, complementation analyses of the isolated ods mutants. All isolated odsts mutants were crossed with the wild-type haploid strain (UR471) or each of the isolated odsts mutants to produce diploid strains. Resultant diploid strains were streaked on two YEALU plates. One was then incubated at 26 °C and the other at 37 °C.

 


Figure 3
View larger version (53K):
[in this window]
[in a new window]

  		FIGURE 3.
RT-PCR analyses of the transcripts from pURA4beta in the wild-type strain (UR471) and ods mutants. The amplified products were electrophoresed on a 5% acrylamide gel, stained with ethidium bromide and visualized under ultraviolet illumination (upper panel). An RT-PCR product derived from an intact ura4+ mRNA produced by exon skipping was detected by Southern blot analysis using an oligonucleotide probe that specifically hybridizes to the exon-skipped spliced product (lower panel). Structures of the RT-PCR products shown on the right were confirmed by the sequence analysis of the products purified from the gel. Arrows indicate positions of the tub-3 and tub-4 primers used for the RT-PCR analysis.

 
Cloning of the ods1+, ods2+, and ods3+ Genes—To clone the ods1+, ods2+, and ods3+ genes, we transformed each ods mutant with an S. pombe genomic library, and isolated clones that were able to complement the ts– growth defects. In the case of the ods1-1 (snh4) mutation, we obtained two cosmid clones that rescued the ts– phenotype: the complementing activity localized to a 9.5-kb XhoI/SacII fragment in a region shared by the two clones (Fig. 4A). That fragment contains the prp2+ gene encoding the large subunit (U2AF59) of the U2 snRNP auxiliary factor (U2AF), which binds to a polypyrimidine tract between the branchpoint sequence and the 3' splice site (18, 19). As only the subcloned fragment that included the complete prp2+ gene could rescue the ts– phenotype, we presumed that the ods1 mutation resides in the prp2+ gene. Sequence analysis of the prp2 gene in ods1-1 revealed a single nucleotide change (G to A) at position 919 of the protein-coding region, which results in replacement of aspartic acid at amino acid 307 of the Prp2 protein with aspargine. The prp2 alleles in the snh25, snh28, and snh32 mutants were found to have the identical mutation. Thus, we categorized these mutant strains as ods1-1. We named snh29 as ods1-2 as it has a C to A change at nucleotide position 1148 of the protein-coding region, which results in replacement of alanine with glutamine at amino acid 383 in the Prp2 protein. Identification of mutations in the prp2 gene in the ods1 mutants establishes that the ods1+ gene is identical with prp2+.

We also isolated ten cosmid clones that rescue the ts– phenotype of ods2-1. Restriction mapping revealed that those clones contained the same DNA insert (data not shown). After subcloning, we found that a 1.5-kb XhoI/NdeI fragment including only the U2AF23 gene is able to complement the ods2-1 (snh19) mutation (Fig. 4B). Sequence analysis of the U2AF23 gene in ods2-1 revealed that there is a C to G change at nucleotide position 447 of the protein-coding region, resulting in replacement of cystein with tryptophan. These results suggest that the ods2 mutation resides in the gene encoding U2AF23, a small subunit of U2AF (20).


Figure 4
View larger version (25K):
[in this window]
[in a new window]

  		FIGURE 4.
Location of ods1+ (A), ods2+ (B), and ods3+ (C) genes and complementing activities of the subcloned genomic fragments. Arrows indicate putative open reading frames. The black arrow denotes the gene responsible for each mutation. Genomic fragments that rescued the temperature sensitivity of each ods mutant are shown by "+".

 


Figure 5
View larger version (47K):
[in this window]
[in a new window]

  		FIGURE 5.
Analyses of exon skipping for the wild-type and mutated pURA4beta plasmids. A, nucleotide sequences of the mutated regions in the pURA4beta plasmid. Mutated sequences are shown under the wild-type sequences. B, growth abilities of the transformants harboring the wild-type pURA4beta (row 1) or mutated pURA4beta (rows 2–8) were tested on an MM plate. Each transformant was suspended in water, adjusted to 105 cells/ml, diluted three times (10-fold each), spotted on the MM plate, and then incubated at 26 °C. In the schematic representation of the mutated reporter gene, mutations at the branchpoint sequence, its downstream region and the 3' splice site in the first intron, and the 5' splice site in the second intron are represented by a triangle, circle, diamond, and star, respectively. C, RT-PCR and Southern blot analyses of the transcripts from the mutated pURA4beta. Total RNAs were isolated from the transformants and subjected to RT-PCR analysis with primers that recognize ura4+ sequences. The amplified products were fractionated on a 5% polyacrylamide gel, followed by Southern blot analyses with the probe for the exon-skipped product. The upper bands observed in lanes 1 and 2 derived from aberrantly amplified products during the PCR reaction. Structures of the RT-PCR products shown on the right were confirmed by the sequence analysis of the products purified from the gel.

 
As for the cloning of the ods3+ gene, we isolated 21 clones able to complement the ts– phenotype of ods3-1 (snh33). Of those, we analyzed three independent clones. Restriction mapping analysis revealed that those clones contain the same overlapped genomic region of 4410 bp in length. In that overlapped region, there is a single complete ORF (SPCC962.06c), which encodes S. pombe SF1 (Fig. 4C). Sequence analysis of the sf1 gene in ods3-1 revealed that there is a C to A change at nucleotide position 301 of the protein-coding region, resulting in replacement of glutamine with lysine at amino acid 101 of the SF1 protein. snh33 and snh34 contained the same C to A mutation described above; both alleles were designated as ods3-1. SF1 has been shown to form a tight complex with U2AF59 and U2AF23 that may represent the earliest pre-spliceosome complex in S. pombe (21).

Mutations in the SF1-U2AF 59-U2AF23 Binding Sequence in the First Intron Cause Exon Skipping—We found that the genes responsible for the ods1, ods2, and ods3 mutations encode components of the SF1-U2AF59-U2AF23 complex, suggesting that the complex plays an important role to ensure ordered exon joining during the splicing reaction. To examine further requirement of the SF1-U2AF59-U2AF23 complex in ordered splicing, we mutagenized the sequence of the binding site region for the SF1-U2AF59-U2AF23 complex (21), that is, the region spanning from the branch site to the 3' splice site, in the chimeric ura4+ gene, as shown in Fig. 5A. The putative branch site sequence GCTAAT, which matches the S. pombe branch site consensus sequence PuCT-PuAPy (Pu, purine; Py, pyrimidine) (22), was changed to GTGATT and two pyrimidines between the branch site and the 3' splice site were changed to A. The conserved 3' splice site AG was also mutagenized to CT. In addition to those mutations, we generated a mutation in the 5' splice site of the second intron. The mutations were introduced into the ura4 reporter gene plasmid in all combinations. The efficiency of exon-skipping was then evaluated by growth of transformants on MM plates and Southern blot analyses of the RT-PCR products amplified from total RNAs prepared from the transformants.

Fig. 5B shows the results of the growth test on MM plates. The cells transformed with the plasmid containing the mutation at the 5' splice site could not grow on MM, suggesting that, as with the unmutated ura4beta construct in wild-type cells, exon skipping did not occur, which was confirmed by Southern blot analysis (Fig. 5C, lanes 1 and 2). In contrast, the transformants with the plasmid carrying the branch site mutation grew well on MM (Fig. 5B), and the product of exon skipping was detected by Southern blot analysis (Fig. 5C, lanes 3, 4, 6, and 7). Interestingly, the mutation of the branch site in the first intron results in accumulation of pre-mRNA containing not only the first intron, but also the second intron, suggesting that the splicing of the second intron was also impaired to some extent by the mutation in the first intron (Fig. 5C, lanes 3 and 4). In the case of the transformant with the 3' splice site mutation (Fig. 5A, mutant 5), growth on MM was slow (Fig. 5B), and the amount of the exon-skipped product was low (Fig. 5C, lane 5). Sequence analysis of the RT-PCR product revealed that a cryptic 3' splice site localized 13 nucleotides downstream of the authentic 3' splice site in the first intron was used for the splicing of this mutant pre-mRNA. In construct 4, combining the 3' splice site and branch point mutations appear to decrease the efficiency of exon skipping compared with construct 3, which has only the branch site mutation (Fig. 5C, lane 4).

Addition of the 5' splice site mutation in the second intron to the branch site mutation in the first intron did not enhance the exon skipping above that produces by the branch point mutation alone (Fig. 5C, compare lanes 3 and 6). As expected, addition of both the 3' splice site mutation in the first intron and the 5' splice site mutation in the second intron to the branch point mutation in the first intron abolished splicing of both the first and second introns separately and promoted exon skipping exclusively (Fig. 5C, lane 7). The plasmid containing mutations of both the 3' and 5' splice sites also caused exon skipping, but the efficiency was lower than that of the gene with the branch site mutation (Fig. 5C, lane 8). These results, which demonstrate that cis-acting mutations in the region recognized by the SF1-U2AF59-U2AF23 complex cause the same type of exon skipping as trans-acting mutations in the subunits, support a role for the SF1-U2AF59-U2AF23 complex in the maintenance of orderly, constitutive splicing in multi-exon pre-mRNAs.

Treatment of the ods Mutants with Drugs That Slow the Transcription Elongation Represses Exon Skipping—Recently, Howe et al. (23) found that exon skipping in S. cerevisiae is suppressed when transcription is slowed by treatment of cells with 6-azauracil (6-AU) or mycophenolic acid (MPA), inhibitors of nucleotide biosyntheis that deplete cellular nucleotide pools required for efficient transcription by RNA polymerase (23). Based on this phenomenon, Howe et al. (23) speculated that a drug-induced reduction in the rate of transcript elongation relative to splicing represses exon skipping by allowing more time for branchpoint recognition in the first intron to occur before the second intron is transcribed.

Using our pURA4beta reporter system, we examined how the rate of transcriptional elongation affects the fidelity of ordered exon joining in the ods mutants. We found that both 6-AU (0.08 mg/ml) and MPA (0.1 mg/ml) induced impaired growth of ods mutant cells on MM at 26 °C, suggesting suppression of exon skipping (data not shown), which was confirmed by the reduction of the exon-skipped product detected by RT-PCR followed by Southern blot analysis with the probe specific for the exon-skipped product (Fig. 6). As the amounts of the constitutively spliced chimeric ura4 product (Fig. 6, upper left panel) and actin transcript (lower left panel) were not changed, decrease of the exon-skipped product seems not to be the outcome from the general inhibition of the transcription. Rather, it appears that a shift in the choice of splicing pathway from exon skipping to exon inclusion has occurred as a result of the slowed elongation of the nascent transcript.


Figure 6
View larger version (28K):
[in this window]
[in a new window]

  		FIGURE 6.
Treatment of cells with drugs that reduce the rate of transcription elongation suppresses exon skipping. Cells with pURA4beta were cultured for 4 h at 26°C in MM medium containing 0.08 mg/ml of 6-AU or 0.1 mg/ml of MPA. Total RNAs were then prepared and subjected to RT-PCR analysis (left panel), followed by Southern blot analysis (right panel) to detect the exon-skipped product indicated by the arrow on the right. RT-PCR of actin mRNA was also performed as a control.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
To understand the molecular mechanisms that ensure ordered exon joining in constitutive splicing, we screened for mutations that cause exon-skipping during splicing of the pre-mRNA transcribed from a reporter gene and found that all of the mutations fell within the three genes that encode the subunits of the SF1-U2AF59-U2AF23 complex, which is essential for the recognition of the branchpoint sequence and the 3' splice site (2). Cis-acting mutations that reproduced the exon skipping phenotype of the mutations in the SF1-U2AF59-U2AF23 complex confirmed the importance of branchpoint recognition in the maintenance of ordered exon joining.

In the isolated ods mutants, the amounts of the exon-skipped products detected were low, although those were sufficient to support growth of the plasmid-bearing mutants on MM (Figs. 2 and 3). ods mutations would also affect splicing of pre-mRNAs from endogenous genes, in addition to splicing of transcripts from the pURA4beta reporter plasmid. Actually, we detected a small amount of exon 2-skipped transcripts from the endogenous nda3+ gene in the ods1-1 mutant (data not shown). As severe splicing perturbations result in cell mortality, ods alleles that cause strong induction of exon skipping are expected to be difficult to recover in our screening.

We showed that mutating the 5' splice site of the second intron produced exclusive retention of the mutated intron during splicing, in contrast to the case of vertebrates that causes exon skipping (24). This result indicates that splicing in fission yeast is conducted via intron definition, which is consistent with the data reported by Romfo et al. (25).


Figure 7
View larger version (16K):
[in this window]
[in a new window]

  		FIGURE 7.
A hypothetical transcription-coupled ordered splicing model. A, Prp40p-U1 snRNP, which binds to both the CTD of elongating RNA polymerase II and the SF1-U2AF59-U2AF23 complex, recognizes the 5' splice site in a nascent RNA (I). After the branchpoint sequence indicated by a closed circle is synthesized, the SF1-U2AF59-U2AF23 complex paired with Prp40p-U1 snRNP recognizes it, forming a commitment complex (II), which after release from the CTD, initiates spliceosome formation and the splicing reaction proceeds. New Prp40p-U1 snRNP and SF1-U2AF59-U2AF23 complexes are then recruited to the CTD for the splicing of the next intron in the nascent transcript (III). B, mutations in the SF1-U2AF59-U2AF23 complex or in the branchpoint region of the intron 1 that weaken its recognition (I) provide a greater opportunity to bridge between the 5' splice site in the first intron and the 3' splice site in the second intron, which results in exon skipping (II).

 
In addition to induction of exon skipping, branchpoint mutations that block splicing of the first intron decreases the splicing efficiency of the second intron, leading to accumulation of the unspliced pre-mRNA (Fig. 5C, lanes 3 and 4). Contrary, the 5' splice site mutation in the second intron neither significantly reduces the efficiency of the first intron splicing, nor induces exon skipping (Fig. 5C, lane 2). There might be a mechanism that represses splicing of the downstream intron when splicing of the preceding intron is inhibited, besides a mechanism that induces exon skipping.

In S. pombe, SF1 was shown to bind U2AF59 and U2AF23 and form a stable complex required for pre-spliceosome complex A formation (21). Genetic and biochemical experiments in S. cerevisiae have shown that BBP (a homologue of SF1) interacts directly with both Mud2p (a homologue of U2AF65) and the U1 snRNP protein Prp40p (26). As BBP and Prp40p are involved in recognition of the branchpoint sequence and the 5' splice site, respectively, the interaction is thought to define bridging between the two ends of an intron (26). In mammals, SF1 interacts with U2AF65 and with U1C through FBP21, a Prp40p like protein, indicating that the interaction between SF1 and Prp40p is conserved among organisms (26). Interestingly, S. cerevisiae Prp40p was shown to bind the phosphorylated C-terminal domain (CTD) of elongating RNA polymerase II, suggesting co-transcriptional formation of a commitment complex for splicing (27).

In S. cerevisiae, mutations in the DYN2 gene that reduce recognition of the branchpoint sequence in the first intron cause exon skipping, indicating that efficient recognition of the first intron is important for exon inclusion (23). In addition, treatment of cells with inhibitors for nucleotide biosynthesis that reduce the rate of transcription elongation was found to inhibit exon skipping in vivo. Those observations are consistent with the predictions of the previously proposed "first come, first served" model, which suggest the co-transcriptional recognition of splice sites (28).

In this report, we provided another evidence supporting the "first come, first served" model in S. pombe. We found that mutations in the SF1-U2AF59-U2AF23 complex or the reporter gene that affect branchpoint recognition enhances exon skipping in S. pombe. We also showed that drugs that slow transcription elongation suppress exon skipping in the ods mutants, suggesting that co-transcriptional recognition of a nascent pre-mRNA by the SF1-U2AF59-U2AF23 complex is essential for ordered 5' to 3' exon joining. Taken together with the previously reported results mentioned above, we propose the ordered splicing model shown in Fig. 7. In this model, the U1 snRNP bound to the CTD of elongating RNA polymerase II through Prp40p recognizes the 5' splice site of a nascent transcript first, and then the SF1-U2AF59-U2AF23 complex associated with U1 snRNP through Prp40p recognizes the branchpoint sequence and the 3' splice site, which appears in the transcript as transcription proceeds (Fig. 7A). In this model, the association between U1 snRNP and the SF1-U2AF59-U2AF23 complex via Prp40p assures co-transcriptional ordered exon joining. In the ods mutants, reduced fidelity of the branchpoint recognition in the first intron by mutations in the SF1-U2AF59-U2AF23 complex might induce exon skipping (Fig. 7B). If U1 snRNP is stalled at the 5' splice site of the first intron, as shown in Fig. 7B, then recognition of the 5' splice site of the second intron by U1 snRNP would be hampered, which may explain a mechanism for repression of the second intron splicing by mutations in the first intron (Fig. 5C).

The vast majority of metazoan pre-mRNAs have multiple introns, which typically range in size from 103 to 104 nucleotides. Exons in these pre-mRNAs are relatively short, averaging less than 200 nucleotides. It has been thought that initial splice site recognition in metazoan pre-mRNAs is established across a short exon (exon definition), rather than across an intron with long length (29). In S. pombe, in contrast, introns are short (the average size is 107 nucleotides) relative to exons that appear not to be constrained in size (30). Thus, there is less of a need for a system that recognizes exons in this organism. In S. pombe, a system with a strong dependence on recognition of the branch-point-3' splice site sequence by the SF1-U2AF59-U2AF23 complex might have evolved to make sure that a spliceosome is not assembled until both the 5' and 3' splice sites in an intron are recognized.


   FOOTNOTES
 
* This work was supported by grants from the Ministry of Education, Science, Technology, Sports and Culture of Japan (to T. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 To whom correspondence should be addressed: Dept. of Sciences, Graduate School of Science and Technology, Kumamoto University, Kumamoto 860-8555, Japan. Tel. & Fax: 81-96-342-3461; E-mail: ttani{at}sci.kumamoto-u.ac.jp.

2 The abbreviations used are: snRNP, small nuclear ribonucleoprotein particle; U2AF, U2 snRNP auxiliary factor; ods, ordered splicing; 6-AU, 6-azauracil; MPA, mycophenolic acid; CTD, C-terminal domain; ts, temperature sensitive. Back


   ACKNOWLEDGMENTS
 
We thank M. Gillespie for help with the construction of pURA4beta, N. Proudfoot and T. Humphrey for the gift of pURA4, and M. Yanagida for the gift of the cloned nda3+ gene.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Brow, D. A. (2002) Annu. Rev. Genet 36, 333–360[CrossRef][Medline] [Order article via Infotrieve]
  2. Reed, R. (2000) Curr. Opin. Cell Biol. 12, 340–345[CrossRef][Medline] [Order article via Infotrieve]
  3. Modrek, B., and Lee, C. (2002) Nat. Genet. 30, 13–19[CrossRef][Medline] [Order article via Infotrieve]
  4. Lopez, A. J. (1998) Annu. Rev. Genet 32, 279–305[CrossRef][Medline] [Order article via Infotrieve]
  5. Black, D. L. (2003) Annu. Rev. Biochem. 72, 291–336[CrossRef][Medline] [Order article via Infotrieve]
  6. Wood, V. (2002) Nature 415, 871–880[CrossRef][Medline] [Order article via Infotrieve]
  7. Okazaki, K., and Niwa, O. (2000) DNA Res. 7, 27–30[Abstract]
  8. Habara, Y., Urushiyama, S., Tani, T., and Ohshima, Y. (1998) Nucleic Acids Res. 26, 5662–5669[Abstract/Free Full Text]
  9. Blandin, G., Durrens, P., Tekaia, F., Aigle, M., Bolotin-Fukuhara, M., Bon, E., Casaregola, S., de Montigny, J., Gaillardin, C., Lepingle, A., Llorente, B., Malpertuy, A., Neuveglise, C., Ozier-Kalogeropoulos, O., Perrin, A., Potier, S., Souciet, J., Talla, E., Toffano-Nioche, C., Wesolowski-Louvel, M., Marck, C., and Dujon, B. (2000) FEBS Lett. 487, 31–36[CrossRef][Medline] [Order article via Infotrieve]
  10. Gutz, H., Heslot, H., Leupold, U., and Loprieno, N. (1974) in Handbook of Genetics (King, R. C., ed) pp. 395–446, Plenum Press, New York
  11. Sherman, F., Flink, G. R., and Hicks, J. B. (1986) Methods in Yeast Genetics: A Laboratory Course Manual, pp. 61–62, Cold Spring Harbor Laboratory Press, New York
  12. Alfa, C., Fantes, P., Hyams, J., McLeod, M., and Warbrick, E. (1993) Experiments with Fission Yeast, Cold Spring Harbor Laboratory Press, New York
  13. Hiraoka, Y., Toda, T., and Yanagida, M. (1984) Cell 39, 349–358[CrossRef][Medline] [Order article via Infotrieve]
  14. Humphrey, T., Sadhale, P., Platt, T., and Proudfoot, N. (1991) EMBO J. 10, 3503–3511[Medline] [Order article via Infotrieve]
  15. Urushiyama, S., Tani, T., and Ohshima, Y. (1997) Genetics 147, 101–115[Abstract]
  16. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., pp. 568–572, Cold Spring Harbor Press, Cold Spring Harbor, NY
  17. Gatermann, K. B., Hoffman, A., Rosenberg, G. H., and Käufer, N. F. (1989) Mol. Cell Biol. 9, 1526–1535[Abstract/Free Full Text]
  18. Potashkin, J., Naik, K., and Wentz-Hunter, K. (1993) Science 22, 573–575
  19. Ramfo, C. M., Lakhe-Reddy, S., and Wise, J. A. (1999) RNA 5, 49–65[Abstract]
  20. Webb, C. J., and Wise, J. A. (2004) Mol. Cell. Biol. 24, 4229–4240[Abstract/Free Full Text]
  21. Huang, T., Vilardell, J., and Query, C. C. (2002) EMBO J. 21, 5516–5526[CrossRef][Medline] [Order article via Infotrieve]
  22. Kuhn, A. N., and Käufer, N. F. (2003) Curr. Genet. 42, 241–251[Medline] [Order article via Infotrieve]
  23. Howe, K. J., Kane, C. M., and Ares, M., Jr. (2003) RNA 9, 993–1006[Abstract/Free Full Text]
  24. Robberson, B. L., Cote, G. J., and Berget, S. M. (1990) Mol. Cell. Biol. 10, 84–94[Abstract/Free Full Text]
  25. Romfo, C. M., Alvarez, C. J., van Heeckeren, W. J., Webb, C. J., and Wise, J. A. (2000) Mol. Cell. Biol. 20, 7955–7970[Abstract/Free Full Text]
  26. Abovich, N., and Rosbash, M. (1997) Cell 89, 403–412[CrossRef][Medline] [Order article via Infotrieve]
  27. Morris, D. P., and Greenleaf, A. L. (2000) J. Biol. Chem. 275, 39935–39943[Abstract/Free Full Text]
  28. Aebi, M., and Weissmann, C. (1987) Trend Genet. 3, 102–107[CrossRef]
  29. Berget, S. M. (1995) J. Biol. Chem. 270, 2411–2414[Free Full Text]
  30. Kupfer, D. M., Drabenstot, S. D., Buchanan, K. L., Lai, H., Zhu, H., Dyer, D. W., Roe, B. A., and Murphy, W. (2004) Euk. Cells 3, 1088–1100

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/4/2221    most recent
M609430200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haraguchi, N.
Right arrow Articles by Tani, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haraguchi, N.
Right arrow Articles by Tani, T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.